INCREASED LEVELS OF CIRCULATING NITRATES AND IMPAIRED ENDOTHELIUM-MEDIATED VASODILATION SUGGEST MULTIPLE ROLES OF NITRIC-OXIDE DURING ACUTEREJECTION OF PULMONARY ALLOGRAFTS
L. Wiklund et al., INCREASED LEVELS OF CIRCULATING NITRATES AND IMPAIRED ENDOTHELIUM-MEDIATED VASODILATION SUGGEST MULTIPLE ROLES OF NITRIC-OXIDE DURING ACUTEREJECTION OF PULMONARY ALLOGRAFTS, The Journal of heart and lung transplantation, 16(5), 1997, pp. 517-523
Citations number
43
Categorie Soggetti
Cardiac & Cardiovascular System",Transplantation,"Respiratory System
Experiments were designed to determine whether changes in pulmonary ar
tery function could be reduced by treatment with a lipid peroxidation
inhibitor (H 290/51) during acute rejection of pulmonary allografts. S
ingle lung transplantation was performed in three groups of dogs: grou
p 1 was maintained on immunosuppression for 8 days after operation (im
munosuppressed, n = 5); in group 2, immunosuppression was discontinued
on postoperative day 5, so that rejection occurred on postoperative d
ay 8 (rejecting, n = 6); in group 3, immunosuppression was discontinue
d after 5 days, and the lipid peroxidation inhibitor H 290/51 (25 mg/k
g) was given perorally for 3 days (rejecting + H 290/51, n = 6). Plasm
a nitric oxide (NOx) was measured by use of chemoluminescence. On post
operative day 8 rejection was observed in groups 2 and 3. Contractions
to angiotensin I and endothelium-dependent relaxations to adenosine d
iphosphate were reduced in pulmonary arteries from rejecting lungs, Re
sponses of rings from dogs treated with H 290/51 were similar to those
from rejecting lungs. Rejection did not alter relaxations to exogenou
s nitric oxide. However, plasma levels of NOx increased significantly
during rejection independently of treatment with H 290/51. Results of
this study confirm that endothelium-dependent relaxation of pulmonary
arteries is reduced during acute rejection of lung allografts. The res
ult extends these observations to suggest that treatment with a lipid
peroxidation inhibitor neither protects the pulmonary artery function
nor affects levels of circulating NOx. Therefore mechanisms other than
lipid peroxidation participate in vascular changes associated with al
lograft rejection.